Mehran Sugar Mills Limited (PSX:MRNS)
Pakistan · Delayed Price · Currency is PKR 59.78
+1.78 (3.07%)
At close: Mar 5, 2026
Mehran Sugar Mills Employees
Mehran Sugar Mills had 275 employees as of September 30, 2025. The number of employees decreased by 3 or -1.08% compared to the previous year.
Employees
275
Change (1Y)
-3
Growth (1Y)
-1.08%
Revenue / Employee
40.06M PKR
Profits / Employee
7.80M PKR
Market Cap
4.48B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 275 | -3 | -1.08% |
| Sep 30, 2024 | 278 | 0 | - |
| Sep 30, 2023 | 278 | 20 | 7.75% |
| Sep 30, 2022 | 258 | -66 | -20.37% |
| Sep 30, 2021 | 324 | -5 | -1.52% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bunny's | 1,248 |
| Matco Foods | 900 |
| At-Tahur | 733 |
| Al-Noor Sugar Mills | 697 |
| The Thal Industries Corporation | 674 |
| Habib Sugar Mills | 599 |
| Shahmurad Sugar Mills | 375 |
| The Organic Meat Company | 352 |
Mehran Sugar Mills News
- 1 year ago - MARINUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marinus Pharmaceuticals, Inc. - MRNS - Business Wire
- 1 year ago - Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc. - Business Wire
- 1 year ago - Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results - Business Wire
- 1 year ago - Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives - Business Wire
- 1 year ago - Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual Meeting - Business Wire
- 1 year ago - 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity - Benzinga
- 1 year ago - Marinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY® Titration Regimens - Business Wire
- 1 year ago - Marinus Pharmaceuticals Announces Podium and Poster Presentations at the Neurocritical Care Society 2024 Annual Meeting - Business Wire